Joseph Scandura

23PUBLICATIONS
132CO-AUTHORS
Respiratory diseasesHaematological tumoursMolecular targetsMedical microbiology not elsewhere classifiedBasic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 13, 2026
Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.

|Feb 23, 2026
CAR-T Targeting of Mutant Calreticulin Establishes a Potentially Curative Stem Cell-Directed Therapy for Myeloproliferative Neoplasms.

Daniel C Choi, Giovanni Medico, Irina V Lebedeva

|Dec 10, 2025
Toward new therapy end points in polycythemia vera: targeting clonal and inflammatory pathways.

Tiziano Barbui, Joseph Michael Scandura

|Jul 07, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.

Giulia Petroni, Claudia Galassi, Kenneth H Gouin

|Apr 15, 2025
DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.

Ghaith Abu-Zeinah, Katie Erdos, Neville Lee

|Mar 11, 2025
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial.

Raajit K Rampal, Sebastian Grosicki, Dominik Chraniuk

Pageof 4

Frequent Collaborators

8 joint publications

Ghaith Abu-Zeinah

4 joint publications

Daniel Choi

3 joint publications

Richard T Silver

2 joint publications

Raajit K Rampal